Learn More
Medchemexpress LLC Rezvilutamide (SHR3680) | 1572045-62-5 | 99.8% | C22H20F3N3O4S | 10MG

Supplier: Medchemexpress LLC HY13744810MG
Rezvilutamide (SHR3680) is an orally active, nonsteroidal androgen receptor antagonist used in preclinical and pharmacological studies of prostate cancer to inhibit androgen receptor signaling and study therapeutic response.
- Orally active androgen receptor antagonist for prostate cancer research.
- High purity (≈99.8%).
- Molecular formula C22H20F3N3O4S; molecular weight 479.47.
- Supplied as a white to off-white solid and as a DMSO solution for convenience.
- Soluble in DMSO (100 mg/mL), enabling concentrated stock solutions.
- Stable when stored as powder at -20°C and in solution at -80°C for long-term storage.
- Available in small milligram quantities suitable for preclinical experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.